Long-term survival of robotic lobectomy for non-small cell lung cancer: a literature review

Abstract

Even though robotic-assisted surgery is increasingly used for resection of non-small cell lung cancer (NSCLC), data on long-term oncologic outcomes of robotic surgery are still not well defined. The primary endpoint of this review is to analyse the long-term results of robotic lobectomy in NSCLC patients. A systematic research was performed using the PubMed database. Articles published from January 2008 to January 2019 were included. We excluded studies that did not provide results for the long-term outcomes of robotic lobectomy, studies that had fewer than 50 cases and ones that focused on results of sub-lobar resections. Therefore, ten eligible studies were included in this analysis. In total, 2873 patients, with a mean age ranging between 66 and 68 years, who underwent robotic lobectomy for NSCLC, were analysed. Most patients (81%) had early-stage disease. The five-year overall survival for stage I disease fluctuated between 77% and 100%. The five-year disease-free survival was reported to be near 73%. We can conclude that robotic assisted lobectomy is an effective minimally-invasive procedure for lung resection. The current literature shows that robotic lobectomy is associated with long-term survival and lasting disease-free survival, equivalent to those reached by video-assisted thoracic surgery and open approach.

Keywords

Non-small cell lung cancer / robotic surgery / robotic lobectomy / long-term outcome / minimally invasive surgery

References

[1] NCCN guidelines, Version 5.2019, NSCLC. Available from https://www.nccn.org/professionals/physician_gls/default.aspx [Last accessed on 31 Dec 2019]

[2] Paul S,Sheng S,Harpole DH.Thoracoscopic lobectomy is associated with lower morbidity than open lobectomy: a propensity-matched analysis from the STS database..J Thorac Cardiovasc Surg2010;13:366-78

[3] Yang CJ,Klapper JA,Tong BC.A national analysis of long-term survival following thoracoscopic versus open lobectomy for stage I non-small-cell lung cancer..Ann Surg2019;269:163-71

[4] Berry MF,Onaitis MW.Thoracoscopic approach to lobectomy for lung cancer does not compromise oncologic efficacy..Ann Thorac Surg2014;98:197-202 PMCID:PMC4118748

[5] Oh DS,Gorrepati ML,Reed MF.Robotic-assisted, video-assisted thoracoscopic and open lobectomy: propensity matched analysis of recent premier data..Ann Thorac Surg2017;104:1733-40

[6] Toosi K,Glover J,Moodie CC.Upstaging and survival after robotic-assisted thoracoscopic lobectomy for non-small cell lung cancer..Surgery2016;160:1211-8

[7] Yang HX,Sima CS,Adusumilli PS.Long-term survival based on the surgical approach to lobectomy for clinical stage I nonsmall cell lung cancer: comparison of robotic, video-assisted thoracic surgery, and thoracotomy lobectomy..Ann Surg2017;265:431-7 PMCID:PMC5033685

[8] Lee BE,Rutledge J.Nodal upstaging in robotic and video assisted thoracic surgery lobectomy for clinical n0 lung cancer..Ann Thorac Surg2015;100:229-33

[9] Gharagozloo F,Tempesta B.Robot-assisted thoracoscopic lobectomy for early-stage lung cancer..Ann Thorac Surg2008;85:1880-5

[10] Cheufou DH,Ploenes T,Stamatis G.Effectiveness of robotic lobectomy-outcome and learning curve in a high volume center..Thorac Cardiovasc Surg2019;67:573-7

[11] Casiraghi M,Borri A,Romano R.Ten years’ experience in robotic-assisted thoracic surgery for early stage lung cancer..Thorac Cardiovasc Surg2019;67:564-72

[12] Zirafa CC,Ricciardi S,Davini F.Long-term oncologic results for robotic major lung resection in non-small cell lung cancer (NSCLC) patients..Surg Oncol2019;28:223-7

[13] Park BJ,Mussi A,Spaggiari L.Robotic lobectomy for non-small cell lung cancer (NSCLC): long-term oncologic results..J Thorac Cardiovasc Surg2012;143:383-9

[14] Veronesi G,Cerfolio R,Toker A.Robotic resection of Stage III lung cancer: an international retrospective study..Eur J Cardiothorac Surg2018;54:912-9 PMCID:PMC6454562

[15] Cerfolio R,Dylewski M,Spaggiari L.The long-term survival of robotic lobectomy for non-small cell lung cancer: a multi-institutional study..J Thorac Cardiovasc Surg2018;155:778-86 PMCID:PMC5896345

[16] Takagi H,Goto SN,Umemoto T.Perioperative results of robotic lung lobectomy: summary of the literature..Surg Endo2012;26:3697-9

[17] Yang CF,Speicher PJ,Gulack BC.Use and outcomes of minimally invasive lobectomy for stage I non-small cell lung cancer in the National Cancer Data Base..Ann Thorac Surg2016;101:1037-42 PMCID:PMC4763985

[18] Liang H,Zhao L,Zhang J.Robotic versus video-assisted lobectomy/segmentectomy for lung cancer: a metaanalysis..Ann Surg2018;268:254-9

[19] O’Sullivan KE,Hebert AE,Redmond KC.A systematic review and meta-analysis of robotic versus open and video-assisted thoracoscopic surgery approaches for lobectomy..Interact CardioVasc Thorac Surg2019;28:526-34

[20] Goldstraw P,Crowley J,Asamura H.The IASLC lung cancer staging project: proposals for revision of the TNM stage groupings in the forthcoming (eighth) edition of the TNM classification for lung cancer..J Thorac Oncol2016;11:39-51

[21] Wilson JL,Cerfolio RJ,Vallières E.The prevalence of nodal upstaging during robotic lung resection in early stage non-small cell lung cancer..Ann Thorac Surg2014;97:1901-7